Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Stem cells can improve wound healing, reduce scars, promote hair growth, rejuvenate skin, and enhance fat grafts in plastic surgery, but there are still some concerns.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

Cooler scalp temperatures during chemotherapy may prevent hair loss.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Biomedical imaging has greatly improved understanding and treatment of solid tumors.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Guidelines for full-body skin exams, including hidden areas, are needed to guide doctors and inform patients.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

The new drug delivery system improves exemestane's absorption and effectiveness.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.